Clinical pharmacists’ interventions across German hospitals: : results from a repetitive cross-sectional study

ORCID
0000-0003-1249-4223
Affiliation
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Langebrake, Claudia;
Affiliation
Department of Pharmacy, Klinikum Fulda gAG, Fulda, Germany
Hohmann, Carina;
ORCID
0000-0002-4832-4333
Affiliation
Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Lezius, Susanne;
ORCID
0000-0001-7240-1004
Affiliation
Department of Pharmacy, Klinikum Bielefeld Gem. GmbH, Bielefeld, Germany
Lueb, Michael;
Affiliation
Pharmacy, Hannover Medical School, Hannover, Germany
Picksak, Gesine;
Affiliation
Department of Pharmacy, University Hospital Dresden, Dresden, Germany
Walter, Wencke;
Affiliation
Department of Pharmacy, University Hospital Dresden, Dresden, Germany
Kaden, Sandra;
ORCID
0000-0002-4126-4251
Affiliation
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Hilgarth, Heike;
ORCID
0000-0002-2439-0117
Affiliation
Hospital Pharmacy, Klinikum Starnberg GmbH, Academic Teaching Hospital of the Ludwig-Maximilians University, Starnberg, Germany
Ihbe-Heffinger, Angela;
GND
1127775820
Affiliation
Department of Pharmacy, University Hospital Jena
Leichenberg, Katja

Background: Pharmacists’ interventions (PI) are suitable to improve medication safety and optimise patient outcome. However, in Germany, clinical pharmacy services are not yet available nationwide. Aim To gain prospective data on the extent and the composition of routine PI with special focus on intervention rates among German hospital pharmacists during two intervention weeks.

Methods: Within a repetitive cross-sectional study, clinical pharmacists documented all PIs on five days during a one-month period (intervention week) in 2017 and 2019 using the validated online-database ADKA-DokuPIK. Additionally, data regarding the supply structure/level of medical care, the extent of clinical pharmacy services and their professional experience were collected. All data were anonymised before analysis.

Results: In total, 2,282 PI from 62 pharmacists (2017) and 2578 PI from 52 pharmacists (2019) were entered. Intervention rate increased from 27.5 PI/100 patient days in 2017 to 38.5 PI/100 patient days in 2019 ( p  = 0.0097). Frequency of clinical pharmacy services on a daily basis significantly increased from 60% (2017) to 83% (2019). Reasons for PIs from the categories “drugs” (e.g. indication, choice, documentation/transcription) and “dose” were most common in both intervention weeks. The vast majority of underlying medication errors in both intervention weeks were categorised as “error, no harm” (80.3 vs. 78.6%), while the proportion of errors which did not reach the patient, doubled to 39.8% in IW-2019. Conclusion: Regular and daily clinical pharmacy services become more established in Germany and clinical pharmacists are increasingly involved in solving drug related problems proactively and early during the medication management process.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © The Author(s) 2021

Use and reproduction: